New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection

Response-guided therapy for patients with chronic hepatitis who have high viral loads of hepatitis C virus genotype 2

(2012) Yasunori Yamaguchi et al.   HEPATOLOGY RESEARCH

Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads

(2012) Ken Sato et al.   HEPATOLOGY RESEARCH

Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections

(2011) Graham R. Foster et al.   GASTROENTEROLOGY

Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: Meta-analyses of randomized, controlled trials and implications for the future

(2011) Vincent Di Martino et al.   HEPATOLOGY

Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring

(2011) Alessandra Mangia et al.   HEPATOLOGY

Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b

(2011) Naoya Sakamoto et al.   JOURNAL OF MEDICAL VIROLOGY

New direct-acting antivirals' combination for the treatment of chronic hepatitis C

(2011) Tarik Asselah et al.   LIVER INTERNATIONAL

Role of interleukin-28B polymorphisms in the treatment of hepatitis C virus genotype 2 infection in Asian patients

(2010) Ming-Lung Yu et al.   HEPATOLOGY

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan

(2010) Hiromitsu Kumada et al.   HEPATOLOGY RESEARCH

Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b

(2010) Tomokazu Kawaoka et al.   JOURNAL OF HEPATOLOGY

Eight-week regimen of antiviral combination therapy with peginterferon and ribavirin for patients with chronic hepatitis C with hepatitis C virus genotype 2 and a rapid virological response

(2010) Hidenori Toyoda et al.   LIVER INTERNATIONAL

Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients

(2009) Thomas Berg et al.   HEPATOLOGY

Early identification of achieving a sustained virological response in chronic hepatitis C patients without a rapid virological response

(2009) Chung-Feng Huang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses

(2009) Y. Inoue et al.   JOURNAL OF VIRAL HEPATITIS

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

(2009) Yasuhito Tanaka et al.   NATURE GENETICS

Meta-analysis: the outcome of anti-viral therapy in HCV genotype 2 and genotype 3 infected patients with chronic hepatitis

(2008) A. ANDRIULLI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Rapid virological response and treatment duration for chronic hepatitis C genotype 1 patients: A randomized trial

(2008) Ming-Lung Yu et al.   HEPATOLOGY